PTGS2 and cancer: However, there still remains a controversy regarding the exact role of COX-2 in NDDs and carcinogenesis, which is further aggravated by the discrepancies between the anti-cancer effects of some COX-2 inhibitors in vitro and their lack of therapeutic efficacy in vivo.